Davidson Kempner Capital Management LP Intra Cellular Therapies, Inc. Transaction History
Davidson Kempner Capital Management LP
- $2.79 Billion
- Q1 2025
A detailed history of Davidson Kempner Capital Management LP transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Davidson Kempner Capital Management LP holds 3,485,058 shares of ITCI stock, worth $460 Million. This represents 16.46% of its overall portfolio holdings.
Number of Shares
3,485,058Holding current value
$460 Million% of portfolio
16.46%Shares
1 transactions
Others Institutions Holding ITCI
# of Institutions
443Shares Held
90.4MCall Options Held
2.24MPut Options Held
1.86M-
Vanguard Group Inc Valley Forge, PA9.52MShares$1.26 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$834 Million0.01% of portfolio
-
Pentwater Capital Management LP Naples, FL5.19MShares$684 Million5.83% of portfolio
-
Ubs Oconnor LLC Chicago, IL3.09MShares$408 Million28.36% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.06MShares$403 Million2.32% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $12.4B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...